Biocept (B00) Ratios
Biocept Ratios
DE:B00's free cash flow for Q2 2023 was $-3.18M. For the 2023 fiscal year, DE:B00's free cash flow was decreased by $-97.00K and operating cash flow was $-3.09M. See a summary of the company’s cash flow.
| Ratios | Mar 23 | Mar 22 | Dec 20 | Dec 19 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 2.97 | 3.88 | 2.61 | 2.50 |
| Quick Ratio | 2.83 | 3.66 | 2.45 | 2.36 |
| Cash Ratio | 2.34 | 2.45 | 1.15 | 1.67 |
| Solvency Ratio | -1.38 | -0.06 | -0.71 | -3.73 |
| Operating Cash Flow Ratio | -2.41 | 0.31 | -1.58 | -4.15 |
| Short-Term Operating Cash Flow Coverage | -113.58 | 2.45 | -20.53 | 0.00 |
| Net Current Asset Value | $ -5.67M | $ 22.75M | $ 8.83M | $ 7.36M |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.39 | 0.21 | 0.26 | 0.14 |
| Debt-to-Equity Ratio | 1.37 | 0.34 | 0.52 | 0.23 |
| Debt-to-Capital Ratio | 0.58 | 0.25 | 0.34 | 0.18 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 3.48 | 1.61 | 2.00 | 1.58 |
| Debt Service Coverage Ratio | -69.55 | -0.56 | -13.81 | -96.47 |
| Interest Coverage Ratio | -101.21 | -8.31 | -65.55 | -92.23 |
| Debt to Market Cap | 0.04 | 0.08 | 0.05 | 0.00 |
| Interest Debt Per Share | 21.99 | 26.32 | 31.57 | 40.51 |
| Net Debt to EBITDA | 0.03 | 18.42 | 0.13 | 0.28 |
| Profitability Margins | ||||
| Gross Profit Margin | -9.99% | 38.34% | 22.30% | -98.56% |
| EBIT Margin | -123.35% | -3.93% | -63.99% | -450.17% |
| EBITDA Margin | -116.95% | -1.44% | -60.34% | -436.18% |
| Operating Profit Margin | -123.69% | -3.93% | -56.33% | -417.05% |
| Pretax Profit Margin | -124.57% | -4.41% | -64.84% | -454.69% |
| Net Profit Margin | -124.09% | -4.61% | -64.84% | -454.69% |
| Continuous Operations Profit Margin | -124.09% | -4.61% | -64.84% | -454.69% |
| Net Income Per EBT | 99.61% | 104.63% | 100.00% | 100.00% |
| EBT Per EBIT | 100.72% | 112.04% | 115.11% | 109.03% |
| Return on Assets (ROA) | -103.93% | -4.67% | -37.53% | -141.76% |
| Return on Equity (ROE) | -362.16% | -7.53% | -75.16% | -224.43% |
| Return on Capital Employed (ROCE) | -126.08% | -4.95% | -44.25% | -189.40% |
| Return on Invested Capital (ROIC) | -117.56% | -4.66% | -41.94% | -167.80% |
| Return on Tangible Assets | -103.93% | -4.67% | -37.53% | -141.76% |
| Earnings Yield | -1071.29% | -15.84% | -101.57% | -1276.27% |
| Efficiency Ratios | ||||
| Receivables Turnover | 12.02 | 4.44 | 1.94 | 1.57 |
| Payables Turnover | 18.67 | 5.21 | 2.55 | 5.46 |
| Inventory Turnover | 37.57 | 14.25 | 11.06 | 14.29 |
| Fixed Asset Turnover | 1.83 | 4.29 | 1.90 | 1.44 |
| Asset Turnover | 0.84 | 1.01 | 0.58 | 0.31 |
| Working Capital Turnover Ratio | 1.16 | 2.27 | 1.93 | 0.00 |
| Cash Conversion Cycle | 20.53 | 37.74 | 77.91 | 191.50 |
| Days of Sales Outstanding | 30.36 | 82.15 | 188.01 | 232.86 |
| Days of Inventory Outstanding | 9.72 | 25.62 | 33.01 | 25.54 |
| Days of Payables Outstanding | 19.55 | 70.03 | 143.11 | 66.89 |
| Operating Cycle | 40.08 | 107.78 | 221.02 | 258.40 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -23.52 | 7.49 | -50.11 | -334.68 |
| Free Cash Flow Per Share | -24.94 | 4.30 | -52.31 | -345.36 |
| Dividend Paid and CapEx Coverage Ratio | -16.47 | 2.35 | -22.83 | -31.35 |
| Capital Expenditure Coverage Ratio | -16.47 | 2.35 | -22.83 | -31.35 |
| Operating Cash Flow Coverage Ratio | -1.10 | 0.29 | -1.62 | -9.07 |
| Operating Cash Flow to Sales Ratio | -0.51 | 0.06 | -0.72 | -4.17 |
| Free Cash Flow Yield | -470.62% | 11.88% | -117.81% | -1207.55% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -0.09 | -6.31 | -0.98 | -0.08 |
| Price-to-Sales (P/S) Ratio | 0.12 | 0.29 | 0.64 | 0.36 |
| Price-to-Book (P/B) Ratio | 0.34 | 0.48 | 0.74 | 0.18 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.21 | 8.42 | -0.85 | -0.08 |
| Price-to-Operating Cash Flow Ratio | -0.23 | 4.83 | -0.89 | -0.09 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.07 | 0.01 | 0.00 |
| Enterprise Value Multiple | -0.07 | -1.86 | -0.93 | 0.20 |
| Enterprise Value | 2.21M | 1.64M | 15.39M | -4.79M |
| EV to EBITDA | -0.07 | -1.86 | -0.93 | 0.20 |
| EV to Sales | 0.09 | 0.03 | 0.56 | -0.87 |
| EV to Free Cash Flow | -0.16 | 0.77 | -0.75 | 0.20 |
| EV to Operating Cash Flow | -0.17 | 0.44 | -0.78 | 0.21 |
| Tangible Book Value Per Share | 15.68 | 76.10 | 60.00 | 162.64 |
| Shareholders’ Equity Per Share | 15.68 | 76.10 | 60.00 | 162.64 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.00 | -0.05 | 0.00 | 0.00 |
| Revenue Per Share | 45.76 | 124.36 | 69.55 | 80.28 |
| Net Income Per Share | -56.78 | -5.73 | -45.10 | -365.01 |
| Tax Burden | 1.00 | 1.05 | 1.00 | 1.00 |
| Interest Burden | 1.01 | 1.12 | 1.01 | 1.01 |
| Research & Development to Revenue | 0.24 | 0.08 | 0.19 | 0.85 |
| SG&A to Revenue | 0.62 | 0.21 | 0.36 | 1.26 |
| Stock-Based Compensation to Revenue | 0.12 | 0.04 | 0.03 | 0.16 |
| Income Quality | 0.41 | -1.31 | 1.11 | 0.92 |
Currency in USD